CS and Alzheimer disease: In both cellular and mouse models of AD, pharmacological activation, or overexpression of PGC1 α protects against nitrosative stress, increases mitochondrial mass as evidenced by increased citrate synthase (CS) activity and OXPHOS levels, reverses mitochondrial dysfunction, and decreases neuronal loss [67].